INTERNATIONAL PATENT: SPLICEBIO, SL FILES APPLICATION FOR "USE OF SPLIT INTEIN FOR THE TREATMENT OF SCN1A ASSOCIATED DISEASE"

GENEVA, March 17 -- SPLICEBIO, SL (Barcelona Science Park Baldiri Reixac, 10-1208028 BARCELONA) filed a patent application (PCT/EP2024/074640) for "USE OF SPLIT INTEIN FOR THE TREATMENT OF SCN1A ASSOCIATED DISEASE" on Sep 04, 2024. With publication no. WO/2025/051758, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FRUTOS, Silvia (c/o SpliceBio, SLBarcelona Science Park Baldiri Reixac, 10-1208028 BARCELONA), CAELLES, Gerard (c/o SpliceBio, SLBarcelona Science Park Baldiri Reixac, 10-1208028 BARCELONA), MOTAS, Sandra (c/o ...